These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36731755)

  • 1. A skin pharmacokinetics study of permeation enhancers: The root cause of dynamic enhancement effect on in vivo drug permeation.
    Ruan J; Liu C; Song H; Zhong T; Quan P; Fang L
    Eur J Pharm Biopharm; 2023 Mar; 184():170-180. PubMed ID: 36731755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of skin diffusion kinetics of isopropyl ester permeation enhancers on drug permeation: Role of lateral spread and penetration characteristics.
    Ruan J; Liao S; Tang J; Ou Y; Hu X; Li J
    Int J Pharm; 2024 Jul; 660():124297. PubMed ID: 38838794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of permeation enhancers: A kinetic evaluation approach and molecular mechanism study in the skin.
    Ruan J; Liu C; Wang J; Zhong T; Quan P; Fang L
    Int J Pharm; 2022 Oct; 626():122155. PubMed ID: 36049584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustainable and efficient skin absorption behaviour of transdermal drug: The effect of the release kinetics of permeation enhancer.
    Ruan J; Liu C; Song H; Zhong T; Quan P; Fang L
    Int J Pharm; 2022 Jan; 612():121377. PubMed ID: 34915145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the enhancement effect of the natural transdermal permeation enhancers from Ledum palustre L. var. angustum N. Busch: Mechanistic insight based on interaction among drug, enhancers and skin.
    Nan L; Liu C; Li Q; Wan X; Guo J; Quan P; Fang L
    Eur J Pharm Sci; 2018 Nov; 124():105-113. PubMed ID: 30153525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The implications of lipid mobility, drug-enhancers (surfactants)-skin interaction, and TRPV1 activation on licorice flavonoid permeability.
    Wang Z; Chen H; Liang T; Hu Y; Xue Y; Wu Y; Zeng Q; Zheng Y; Guo Y; Zheng Z; Zhai D; Liang P; Shen C; Jiang C; Liu L; Shen Q; Zhu H; Liu Q
    Drug Deliv Transl Res; 2024 Jun; 14(6):1582-1600. PubMed ID: 37980702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An investigation on the effect of drug physicochemical properties on the enhancement strength of enhancer: The role of drug-skin-enhancer interactions.
    Xu W; Liu C; Zhang Y; Quan P; Yang D; Fang L
    Int J Pharm; 2021 Sep; 607():120945. PubMed ID: 34363912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time dependence of the enhancement effect of chemical enhancers: Molecular mechanisms of enhancing kinetics.
    Liu X; Quan P; Li S; Liu C; Zhao Y; Zhao Y; Fang L
    J Control Release; 2017 Feb; 248():33-44. PubMed ID: 28088574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Systematic Quantitative Evaluation of Permeation Enhancement Window: Transdermal Permeation Enhancing Dynamics Establishment and Molecular Mechanisms Characterization of Permeation Enhancer.
    Ruan J; Zhong T; Zhang S; Liu C; Quan P; Fang L
    J Pharm Sci; 2022 Jul; 111(7):1962-1972. PubMed ID: 34999089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the permeation enhancer strategy on benzoylaconitine transdermal patch: the relationship between transdermal enhancement strength and physicochemical properties of permeation enhancer.
    Liu C; Farah N; Weng W; Jiao B; Shen M; Fang L
    Eur J Pharm Sci; 2019 Oct; 138():105009. PubMed ID: 31306781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphiphilic transdermal permeation enhancers: structure-activity relationships.
    Vávrová K; Zbytovská J; Hrabálek A
    Curr Med Chem; 2005; 12(19):2273-91. PubMed ID: 16178785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic studies of branched-chain alkanols as skin permeation enhancers.
    Chantasart D; Li SK; He N; Warner KS; Prakongpan S; Higuchi WI
    J Pharm Sci; 2004 Mar; 93(3):762-79. PubMed ID: 14762914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An insight into the molecular mechanism of the temporary enhancement effect of isopulegol decanoate on the skin.
    Liu X; Liu M; Liu C; Quan P; Zhao Y; Fang L
    Int J Pharm; 2017 Aug; 529(1-2):161-167. PubMed ID: 28610893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation design and development of matrix diffusion controlled transdermal drug delivery of glimepiride.
    Akram MR; Ahmad M; Abrar A; Sarfraz RM; Mahmood A
    Drug Des Devel Ther; 2018; 12():349-364. PubMed ID: 29503528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal delivery of highly lipophilic drugs: in vitro fluxes of antiestrogens, permeation enhancers, and solvents from liquid formulations.
    Funke AP; Schiller R; Motzkus HW; Günther C; Müller RH; Lipp R
    Pharm Res; 2002 May; 19(5):661-8. PubMed ID: 12069170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular design of drug-ionic liquids for transdermal drug delivery: Mechanistic study of counterions structure on complex formation and skin permeation.
    Yang D; Liu C; Ding D; Quan P; Fang L
    Int J Pharm; 2021 Jun; 602():120560. PubMed ID: 33798684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impacts of chemical enhancers on skin permeation and deposition of terbinafine.
    Erdal MS; Peköz AY; Aksu B; Araman A
    Pharm Dev Technol; 2014 Aug; 19(5):565-70. PubMed ID: 23841559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic approach to determination of permeation enhancer action efficacy and sites: Molecular mechanism investigated by quantitative structure-activity relationship.
    Yang D; Liu C; Quan P; Fang L
    J Control Release; 2020 Jun; 322():1-12. PubMed ID: 32169535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluations of imidazolium ionic liquids as novel skin permeation enhancers for drug transdermal delivery.
    Zhang D; Wang HJ; Cui XM; Wang CX
    Pharm Dev Technol; 2017 Jun; 22(4):511-520. PubMed ID: 26763663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro release and transdermal fluxes of a highly lipophilic drug and of enhancers from matrix TDS.
    Funke AP; Günther C; Müller RH; Lipp R
    J Control Release; 2002 Jul; 82(1):63-70. PubMed ID: 12106977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.